Alamar Biosciences Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Alamar Biosciences Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- ALMR
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0002104204
Board of directors
-
Frank Witney · DirectorSince 2026
-
Ian W. Ratcliffe · DirectorSince 2026
-
Nicholas Naclerio · DirectorSince 2026
-
Rebecca Chambers · DirectorSince 2026
-
Robert P. Ragusa · DirectorSince 2026
-
Shiping Chen · Director · Chief Operating OfficerSince 2026
-
Yuling Luo · Director · Chief Executive OfficerSince 2026
Chief executives
Yuling Luo
· Chief Executive Officer
Since April 2026
Board connections
2 of this board's directors also sit on 5 other boards.
- via Frank Witney
- via Robert P. Ragusa
- via Frank Witney
- via Frank Witney
- via Robert P. Ragusa
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $7,999,996
- 2 purchases by 2 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 14, 2026 | Brottem John L. Officer (General Counsel) | Grant or award | +29,000 | — | — |
| Sep 1, 2026 | Robert P. Ragusa Director | Grant or award | +5,686 | — | — |
| Apr 20, 2026 | Qiming GP VIII-HC, LLC 10% owner | Derivative conversion | +185,163 | — | — |
| Apr 20, 2026 | Illumina Innovation Fund II GP, L.L.C. 10% owner | Derivative conversion | +4,588,364 | — | — |
| Apr 20, 2026 | White Timothy Ogden Officer (President) | Other | −454,583 | — | — |
| Apr 20, 2026 | Shiping Chen Director, Officer (Chief Operating Officer) | Derivative conversion | +320,511 | — | — |
| Apr 20, 2026 | Yuling Luo Director, Officer (Chief Executive Officer) | Derivative conversion | +1,386,746 | — | — |
| Apr 20, 2026 | McAnear Justin J. Officer (Chief Financial Officer) | Grant or award | +37,220 | — | — |
| Apr 20, 2026 | Nicholas Naclerio Director | Derivative conversion | +4,588,364 | — | — |
| Apr 20, 2026 | Qiming GP VIII-HC, LLC 10% owner | Derivative conversion | +6,881,410 | — | — |
| Apr 20, 2026 | Illumina Innovation Fund II GP, L.L.C. 10% owner | Derivative conversion | +922,152 | — | — |
| Apr 20, 2026 | White Timothy Ogden Officer (President) | Other | +454,583 | — | — |
| Apr 20, 2026 | Shiping Chen Director, Officer (Chief Operating Officer) | Derivative conversion | +72,853 | — | — |
| Apr 20, 2026 | Yuling Luo Director, Officer (Chief Executive Officer) | Derivative conversion | +364,268 | — | — |
| Apr 20, 2026 | Nicholas Naclerio Director | Derivative conversion | +922,152 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.